Follow-The-Filings

Security · featured owners

EDIT Editas Medicine Inc.

COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 1.1%
  • $13M
  • 1 new 1 add 1 reduce

Who owns this now

Largest portfolio weights among featured holders · max 1.1% (James Silverman - Opaleye Management) · not free-float ownership

  1. James Silverman add 1.1%
  2. Nathan Fischel new 0.11%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 1.1% Add +100.4% 3,861,930 $13M history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.11% New 0.11% 170,470 $552K history
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 <0.01% Reduce −4.6% 27,680 $90K history

3 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $78.12M $32.31M $40.52M
Net income -$153.22M -$237.09M -$160.06M
Net margin * -196.1% -733.7% -395.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $340.83M $289.32M $163.9M
Total non-current assets * $158.32M $52.27M $22.64M
Total assets $499.15M $341.59M $186.53M
Total current liabilities $63.22M $77.22M $46.25M
Total non-current liabilities * $86.84M $130.09M $113M
Total equity $349.1M $134.27M $27.29M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$132.18M -$210.28M -$165.24M
Cash from investing -$3.73M $162.15M $138.67M
Cash from financing $118.04M $56.03M $40.47M
Net change in cash -$17.87M $7.89M $13.9M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders